ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,530Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 887

$533K Total Retail Price of All Prescriptions

Rank: 31 out of 887

293 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 293 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 6,773 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 371 258 1 2
LEVOTHYROXINE SODIUM 341 313 2 9
SIMVASTATIN 331 264 3 3
FUROSEMIDE 311 238 4 7
HYDROCODONE-ACETAMINOPHEN 284 196 S3 5 1
GLIMEPIRIDE 202 153 6 54
CRESTOR 202 149 6 25
AMLODIPINE BESYLATE 192 147 8 5
ZOLPIDEM TARTRATE 182 99 9 14
LISINOPRIL 180 120 10 4
METFORMIN HCL ER 168 114 11 50
METFORMIN HCL 163 124 12 8
SERTRALINE HCL 155 118 13 32
ATORVASTATIN CALCIUM 143 92 14 13
HYDROCHLOROTHIAZIDE 142 113 15 10
GABAPENTIN 142 91 15 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 113 17 22
CYCLOBENZAPRINE HCL 110 51 R 18 35
NEXIUM 109 55 19 18
CARVEDILOL 109 89 19 24
FENOFIBRATE 102 51 21 87
PREDNISONE 102 77 21 30
TRAMADOL HCL 93 81 23 15
PRAVASTATIN SODIUM 92 51 24 12
DOXAZOSIN MESYLATE 82 76 25 122
METOPROLOL SUCCINATE 77 65 26 19
CIPROFLOXACIN HCL 76 55 27 60
CLOTRIMAZOLE-BETAMETHASONE 75 49 28 243
ACTOS 75 51 28 101
CLOPIDOGREL 73 63 30 46
AZITHROMYCIN 73 57 30 34
METOPROLOL TARTRATE 71 61 32 16
SYNTHROID 68 54 33 52
WARFARIN SODIUM 67 47 34 26
POTASSIUM CHLORIDE 67 47 34 21
NAPROXEN 67 44 34 99
ALLOPURINOL 67 67 34 66
MECLIZINE HCL 66 55 38 200
METOCLOPRAMIDE HCL 65 37 39 197
ONGLYZA 64 42 40 206
HYDROXYZINE PAMOATE 63 37 R 41 145
RANITIDINE HCL 61 47 42 59
LANTUS SOLOSTAR 60 39 43 86
ESTRADIOL 57 39 R 44 188
TRAMADOL HCL-ACETAMINOPHEN 57 53 44 313
TAMSULOSIN HCL 56 35 46 38
FLUTICASONE PROPIONATE 55 33 47 29
TRAZODONE HCL 55 26 47 27
ZETIA 54 40 49 118
LOSARTAN POTASSIUM 54 29 49 42
CITALOPRAM HBR 53 26 51 23
AMITRIPTYLINE HCL 51 27 R 52 70
MELOXICAM 50 22 53 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.